Skip to content

Sleep Position Pattern Recording

Sleep Position Pattern Recording - A Validation Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06286904
Enrollment
52
Registered
2024-02-29
Start date
2024-04-01
Completion date
2025-03-30
Last updated
2024-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant Women

Keywords

sleep, wearable electronic devices, Pregnant Women, Posture

Brief summary

The main goal of this study is to validate the accuracy of the body position detection by non-invasive wearable monitors (Skiin garments, Myant Medical Corp) during sleep in pregnant participants. This is a first step towards examining the association between maternal sleep position and fetal growth.

Detailed description

Individuals who are eligible to the study and provided consent to participate will be asked to: 1. Wear the Skiin Garment system for the duration of their time in the hospital (minimum 1 nights until they are discharged from hospital). 2. Complete a study completion questionnaire about their experience with the device and the study. The Skiin Garment system is composed by biosensing garments presented in different form factors (bra, chest band, or underwear). It captures physiological metrics and relay information from a pod to local hub with Bluetooth. The true body position will be obtained using visual observations and cameras.

Interventions

DEVICESkiin Garment system

Individuals will be asked to wear a Skiin Garment system for the duration of their hospitalization (minimum one day).The system will collect accelerometer, ECG, temperature, heart rate, steps and sleep metrics data if enable. Then, they will be asked to answer a questionnaire about their experiences with the device and the study.

Sponsors

McMaster University
CollaboratorOTHER
Myant Medical Corp.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Assigned female at birth * Currently pregnant * Admission to MUMC Antenatal Clinic with anticipation of being admitted for greater than 24 hours * Able and willing to provide informed consent to participate

Exclusion criteria

* Unestablished gestational dating (based on first-trimester ultrasound) * Known maternal cardiac or pulmonary disorder * Known sleep disorders (i.e., sleep apnea, periodic limb movement disorder, etc.) * Known fetal chromosomal or structural abnormalities * Known highly sensitive skin/skin sensitivities to textile electrodes

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Skiin Garment system for detecting sleep position of pregnant womenRecorded during the night, during 6 to 8 hours.Sleep position will be identified through the Skiin Garment system via accelerometry, and compared to visual confirmation of sleep position.

Secondary

MeasureTime frameDescription
Questionnaire on wearable device invasiveness and satisfactionOne time point, on the morning after one night wearing the Skiin Garment systemPregnant women will be asked to answer a questionnaire at the end of their participation in the study. It contains questions related to patients' experience wearing the Skiin Garment system, including invasiveness and satisfaction. This is an ad-hoc questionnaire titled SPV\_Satisfaction\_Questionnaire\_v1\_2023-04-03 containing 20 questions: 14 questions use a Likert scale design, 3 questions are single choice answer, and 3 questions are open-ended questions. Results are not reported as a total score on a scale but descriptive statistics will be used individually per question.
Participant recruitment rateFrom the beginning to the end of the recruitment, up to 1 year.Recruitment rate will be calculated as the number of participants who consent to participant divided by the number of participants who consent to be contacted.
Participant retention rateFrom the beginning to the end of participation, up to 1 year.The retention rate will be calculated as the number of participants who remain in the study divided by the number of participants who initially consent to participate.

Countries

Canada

Contacts

Primary ContactEran Ashwal
eran.ashwal@mcmaster.ca905.521.2100
Backup ContactKyle Mcgowan
mcgowank@mcmaster.ca905.521.2100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026